Closing Bell Recap: CRISPR Therapeutics AG (CRSP) Ends at 53.12, Reflecting a -1.55 Downturn

Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

CRISPR Therapeutics AG (NASDAQ: CRSP) closed the day trading at $53.12 down -1.55% from the previous closing price of $53.95. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 1.06 million shares were traded. CRSP stock price reached its highest trading level at $53.98 during the session, while it also had its lowest trading level at $52.52.


For a better understanding of CRSP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.81 and its Current Ratio is at 17.81. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.

TD Cowen Downgraded its Market Perform to Underperform on December 11, 2023, while the target price for the stock was maintained at $30.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 21 ’24 when Bruno Julianne sold 3,366 shares for $56.09 per share. The transaction valued at 188,799 led to the insider holds 6,745 shares of the business.

Kulkarni Samarth sold 19,582 shares of CRSP for $1,173,232 on Apr 15 ’24. The Chief Executive Officer now owns 208,122 shares after completing the transaction at $59.91 per share. On Mar 15 ’24, another insider, Kulkarni Samarth, who serves as the Chief Executive Officer of the company, sold 20,000 shares for $72.48 each. As a result, the insider received 1,449,628 and left with 208,122 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRSP now has a Market Capitalization of 4581334016 and an Enterprise Value of 2637226496. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.60 while its Price-to-Book (P/B) ratio in mrq is 2.16. Its current Enterprise Value per Revenue stands at 9.706 whereas that against EBITDA is -9.452.

Stock Price History:

The Beta on a monthly basis for CRSP is 1.69, which has changed by -0.06454736 over the last 52 weeks, in comparison to a change of 0.23886502 over the same period for the S&P500. Over the past 52 weeks, CRSP has reached a high of $91.10, while it has fallen to a 52-week low of $37.55. The 50-Day Moving Average of the stock is -6.13%, while the 200-Day Moving Average is calculated to be -12.26%.

Shares Statistics:

Over the past 3-months, CRSP traded about 1.35M shares per day on average, while over the past 10 days, CRSP traded about 1410700 shares per day. A total of 84.92M shares are outstanding, with a floating share count of 81.12M. Insiders hold about 4.47% of the company’s shares, while institutions hold 66.52% stake in the company. Shares short for CRSP as of 1718323200 were 14866549 with a Short Ratio of 11.03, compared to 1715731200 on 15334922. Therefore, it implies a Short% of Shares Outstanding of 14866549 and a Short% of Float of 19.860001.

Most Popular